91ÌƲ®»¢

91ÌƲ®»¢ research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.

A collaborative team at 91ÌƲ®»¢ is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.

91ÌƲ®»¢ researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

The 91ÌƲ®»¢ School of Nursing has been approved for a $250,000 award that will support identifying and disseminating strategies for overcoming barriers to patient- and family-centered comparative effectiveness research with patients who are critically ill and hospitalized in an intensive care unit setting.

Growing worries among Grundy County, Tennessee, residents about cancer outbreaks within families, churches and neighborhoods have propelled a community partnership drawing on 91ÌƲ®»¢ University’s strengths to develop environmental and health self-assessment tools. Read More

Mikail Rubinov has been awarded $600,000 from the National Science Foundation to develop new computational methods for analysis of large-scale brain activity data.

An international consortium co-led by 91ÌƲ®»¢'s Rubén Martínez-Barricarte has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. 

Neil Osheroff and his lab provide foundational research for new Urinary Tract Infection antibiotic. UTIs affect half of all women. Read More

91ÌƲ®»¢ School of Nursing has received a $3 million Health Resources and Services Administration grant from the Department of Health and Human Services to create a training program, standardized set of competencies and certification for community health workers in Tennessee.

The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read More

For his work on zoonotic threat mitigation, Lars Plate was awarded $50,000 from the 91ÌƲ®»¢ Corporation for Science Advancement and the U.S. Department of Agriculture. Read More

A company co-founded by 91ÌƲ®»¢ mechanical engineering professor Robert J. Webster III has received a breakthrough device designation from the U.S. Food and Drug Administration that could open the door for new diagnostic and therapeutic applications of flexible endoscopy.

Nashville Biosciences LLC and Illumina Inc. today announced an agreement with Amgen to whole-genome sequence approximately 35,000 DNA samples.

By determining how proteins in different areas of the eye’s lens change over time, 91ÌƲ®»¢ researchers have learned more about how they could contribute to the mysterious progression of cataracts—a clouding of the lens that affects more than 65 million people worldwide each year.   Read More

91ÌƲ®»¢ investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.

College of Arts and Science faculty members Nathan Schley, Allison Walker, and John Yang have each been awarded grants from the National Institutes of Health to continue their groundbreaking chemistry research. The faculty members are conducting big-picture research with practical applications in a variety of health contexts—including drug synthesis, biomolecular conversion, and disease treatment.

91ÌƲ®»¢ researchers in the lab of Erin Calipari, assistant professor of pharmacology and molecular physiology and biophysics, have demonstrated a role for dopamine signaling in novelty-based learning—a finding that could have major impacts on how neurological diseases are treated. Read More

91ÌƲ®»¢ investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.

An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes.

A 91ÌƲ®»¢ study found that higher levels of excess oxygen given to patients under general anesthesia add risk of injury to the kidneys, lungs and heart.